Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Cholesteryl Ester Transfer Assay from US Patent US9493430: "Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as CETP inhibitors"
Assay data:41 Active, 41 Activity ≤ 1 µM, 41 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
In Vitro Radioactive Assays of CETP-Catalyzed CE and TG Transfer (RTA Assay) from US Patent US9353101: "Cyclic amine substituted heterocyclic CETP inhibitors"
Assay data:56 Active, 56 Activity ≤ 1 µM, 56 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Scintillation Proximity Assay (SPA) from US Patent US9353101: "Cyclic amine substituted heterocyclic CETP inhibitors"
Assay data:8 Active, 8 Activity ≤ 1 µM, 8 Tested
CETP Inhibition Assay from US Patent US9321747: "Acid addition salt of substituted pyridine compound"
Assay data:7 Active, 7 Activity ≤ 1 µM, 7 Tested
CETP Inhibition Assay from US Patent US9187450: "Substituted pyridine compound"
CETP In Vitro Assay from US Patent US9150583: "Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation"
Scintillation Proximity Assay (SPA) from US Patent US9126976: "Substituted benzopiperazines as CETP inhibitors"
Assay data:37 Active, 31 Activity ≤ 1 µM, 37 Tested
In Vitro Radioactive (RTA) Assay from US Patent US9126976: "Substituted benzopiperazines as CETP inhibitors"
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
Scintillation Proximity Assay from US Patent US9102599: "N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases"
Assay data:15 Active, 11 Activity ≤ 1 µM, 15 Tested
Scintillation Proximity Assay (SPA) from US Patent US8871738: "Fused bicyclic oxazolidinone CETP inhibitor"
Assay data:74 Active, 68 Activity ≤ 1 µM, 74 Tested
In Vitro Assay from US Patent US8759365: "Organic compounds"
Assay data:22 Active, 22 Activity ≤ 1 µM, 22 Tested
Radioactive Assays of CETP-Catalyzed CE and TG Transfer (RTA Assay) from US Patent US9717714: "Spirocyclic CETP inhibitors"
Assay data:14 Active, 13 Activity ≤ 1 µM, 14 Tested
Inhibition of recombinant CETP (unknown origin) assessed as maximal inhibition of transfer of [3H]cholesteryl oleate or [3H]triolein using exogenous LDL and HDL in 2% human serum at 10 uM measured after 2 hrs by liquid scintillation analysis relative to control
Assay data:10 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of recombinant CETP (unknown origin) assessed as inhibition of transfer of [3H]cholesteryl oleate or [3H]triolein using exogenous LDL and HDL in 2% human serum by liquid scintillation analysis
Assay data:10 Active, 9 Activity ≤ 1 µM, 10 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of recombinant CETP (unknown origin) assessed as maximal inhibition of transfer of [3H]cholesteryl oleate or [3H]triolein between exogenous [3H]LDL in 95% human serum at 10 uM by liquid scintillation analysis
Assay data:42 Tested
Inhibition of recombinant CETP (unknown origin) assessed as inhibition of transfer of [3H]cholesteryl oleate or [3H]triolein between exogenous [3H]LDL in 95% human serum by liquid scintillation analysis
Assay data:48 Active, 43 Activity ≤ 1 µM, 49 Tested
Inhibition of CETP in 95% human serum assessed as inhibition of transfer of [3H] cholesteryl oleate or [3H] triolein between LDL and HDL
Assay data:21 Active, 13 Activity ≤ 1 µM, 22 Tested
Inhibition of recombinant CETP (unknown origin) assessed as inhibition of transfer of [3H] cholesteryl oleate or [3H] triolein between exogenous LDL and HDL in 2% human serum
Assay data:21 Active, 19 Activity ≤ 1 µM, 22 Tested
Inhibition of human CETP
Assay data:5 Active, 1 Activity ≤ 1 µM, 7 Tested
Inhibition of human CETP at 10 uM relative to control
Assay data:16 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on